This move is archived. Current quotes and coverage live on the stock page.
Get TLT alerts:
Theralase Technologies Inc. has seen a significant surge in its stock price, gaining over 8% in just one day.
In the latest trading session, Theralase Technologies Inc. (TLT.V) experienced an impressive rise of 8.33%, closing at CA$0.26. This remarkable performance marks a positive turn for the company, which has been navigating the complexities of the biotech sector. With a market cap of approximately CA$69.5 million, investors are keenly observing its developments.
Advertisement
Theralase Technologies Inc.
TLT.V
TLT.V
Theralase Technologies Inc.
WealthAwesomeMarket cap
$54.70M
52W high
$0.41
52W low
$0.15
1W change
+0.00%
Beta
0.59
Analyst Price Targets
Based on analyst covering TLT
Wall Street analysts forecast TLT stock price to rise 278.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+278.4% Upside
Current Price
C$0.18
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TLT's historical volatility
30-Day Vol
87.1%
Annualized
90-Day Vol
100.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.15
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.17 | C$0.13 โ C$0.24 |
| 60 trading days | C$0.16 | C$0.11 โ C$0.25 |
| 90 trading days | C$0.15 | C$0.09 โ C$0.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Theralase's recent stock surge indicates growing investor confidence, potentially driven by upcoming financial disclosures and ongoing clinical studies.
Theralase Technologies Inc. sees 8.33% increase in stock price
Closing at CA$0.26, TLT.V's surge reflects a growing optimism among investors, though its market cap remains modest at CA$69.5 million.
Bull case
The stock's recent performance might signal positive news ahead for Theralase's clinical studies and financial results. If these developments unfold as expected, they could attract more investment and interest in the company.
Bear case
Despite today's gains, investors should stay cautious. Theralase operates in a volatile sector, facing risks like regulatory hurdles and market fluctuations that could impact its performance.
Recent Performance Highlights
Advertisement
Theralase Technologies Inc. has seen a robust performance in its latest trading session, with an increase of 8.33%. This rise may be attributed to a combination of market sentiment and potential upcoming announcements that could impact investor confidence.
Market Outlook for Theralase
With a market cap of CA$69.5 million, Theralase remains a small-cap player in the biotech industry. Investors should keep an eye on the company's future announcements, especially regarding clinical trials and financial results, which could significantly influence stock performance. For more details on Theralase's financials, check out their latest Q1 2026 Financial Statements.
Investor Sentiment and Future Prospects
The recent stock surge has sparked discussions among investors about Theralase's growth potential. As the company continues to innovate and expand its offerings, the market will be watching closely for any developments that could propel the stock further. For insights on their recent offerings, see the announcement about their C$4 million Brokered LIFE Offering.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
